Tag: vagus nerve stimulation
Tivic completes enrolment in study of non-invasive, bioelectronic VNS therapy
Tivic Health Systems has announced that enrolment in its pilot clinical study of a proprietary approach to non-invasive vagus nerve stimulation (VNS) has been completed....
Brain stimulation plus rehabilitation produces improved upper-limb function in stroke survivors
Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover movement in their arms and hands, and maintain these improvements for one year, within a...
Non-invasive VNS approach could enhance post-stroke recovery outcomes
A novel approach to vagus nerve stimulation (VNS) may enable successful post-stroke recovery without the need for “invasive and often-uninsured” traditional VNS therapies.
A paper published...
Evren Technologies launches Phoenix 100 system for vagus nerve stimulation research
Evren Technologies has announced the launch of its Phoenix 100 system, a “state-of-the-art” transcutaneous auricular vagus nerve stimulator (taVNS) research tool.
The Phoenix 100 system is intended...
LivaNova announces randomisation of 150th bipolar depression patient in RECOVER clinical...
LivaNova has announced that the 150th bipolar depression patient has been randomised in its RECOVER clinical study—a prospective, multicentre, double-blinded randomised controlled trial investigating...
RECOVER trial will provide “thorough understanding” of VNS response in depression...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding”...
Feinstein Institutes reports on early vagus nerve mapping and details novel...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) are microscopically mapping more than 100,000 individual fibres that make up the vagus nerve...
LivaNova launches new vagus nerve stimulation therapy for drug-resistant epilepsy
LivaNova has launched SenTiva DUO—an implantable pulse generator (IPG) with a dual-pin header intended to provide vagus nerve stimulation (VNS) therapy for patients with...
First commercial Vivistim patient set to begin paired vagus nerve stimulation...
MicroTransponder recently announced the first commercial use of its Vivistim paired vagus nerve stimulation (VNS) system for improved upper-limb function post-stroke. The company said...
Dolphin vagal nerve stimulator gains Health Canada nod for ‘long-haul’ COVID-19...
Health Canada recently authorised the Dolphin vagal nerve stimulator to treat symptoms in patients with COVID-19 ‘long-haul’ symptoms (long haulers). Long haulers experience a wide variety of aftereffects...
Dolphin vagus nerve stimulation receives Health Canada approval as COVID-19 treatment
Center for Pain and Stress Research today announced that its Dolphin vagus nerve stimulation (VNS) device has received breakthrough approval from Health Canada—making it...
Feinstein Institutes scientists develop “first-of-its-kind” wireless neuromodulation device for research
Engineers and researchers in the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research have developed a novel, fully implantable, wireless bidirectional vagus nerve stimulation (VNS)...
MicroTransponder receives best new product award for Vivistim system
MicroTransponder today announced that its Vivistim paired vagus nerve stimulation (VNS) system has won the Neurotech Reports Gold Electrode Award for best new product. This announcement...
MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...
MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...
New study shows significant positive impact of vagus nerve stimulation therapy...
Adding vagus nerve stimulation (VNS) therapy to treatment as usual (TAU) has been demonstrated to improve outcomes in patients with treatment-resistant bipolar depression (TRBD)....
Non-invasive vagus nerve stimulation may provide clinical benefit to patients with...
An article accepted into the journal Neuromodulation has concluded that, based on two case reports, non-invasive vagus nerve stimulation (nVNS) might provide clinical benefits...
Cervical non-invasive vagus nerve stimulation effectively relieves pain in migraine sufferers
A recent meta-analysis demonstrated that cervical non-invasive vagus nerve stimulation (nVNS) is a safe and effective method for acute pain relief in migraine and...
LivaNova collaborates with Verily to fuel research into vagus nerve stimulation...
LivaNova has announced a research collaboration with Verily, an Alphabet company, to capture measures of depression within its RECOVER clinical study, which is evaluating...
News from NANS: First long-term vagus nerve stimulation implant in mice
Data showing the effective use of a long-term vagus nerve implant in mice have been presented at the North American Neuromodulation Society’s (NANS) annual...
LivaNova enrols first patient in RECOVER clinical study
LivaNova has announced the first patient enrolled in their RECOVER trial, a prospective, multi-centre, randomised controlled blinded trial demonstrating the safety and effectiveness of...
CMS trial clearance for LivaNova’s vagus nerve stimulation therapy for treatment-resistant...
LivaNova has recognised that the US Centers for Medicare & Medicaid Services (CMS) finalised its National Coverage Determination (NCD) for the LivaNova vagus nerve...
FDA approves SenTiva device for treatment of epilepsy
LivaNova has received US Food and Drug Administration (FDA) approvals for its latest Vagus Nerve Stimulation (VNS) Therapy System, which consists of the SenTiva implantable...
LivaNova’s VNS Therapy receives FDA approval for expanded MRI labelling
LivaNova’s latest vagus nerve stimulation (VNS Therapy) system has received US Food and Drug Administration (FDA) approval for expanded magnetic resonance imaging labelling.
According...
